Such an increase in D2R signalling could contribute to the imbalance in DAergic neurotransmission characteristic of schizophrenia, i.e., hyperfunction through D2R and attenuation of such hyperfunction by current D2R antagonist antipsychotics (McCutcheon et al., 2019). This evidence concerns the gene DRD2 and schizophrenia.